# Kun Ling Capital

> Kun Ling Capital is a VC fund in Shanghai backing Health Care, Medical and EdTech. See 8 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Shanghai, China
- Total investments: 8
- Last investment: Apr 2026
- Lead investor: 25%
- Last updated: Aug 2026
- Website: http://www.kunling-capital.com/

Kun Ling Capital is a private equity investment firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 38% |
| Medical | 2 | 25% |
| EdTech | 1 | 13% |
| mHealth | 1 | 13% |
| Software | 1 | 13% |

20 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 3 | 38% |
| Series F | 3 | 38% |
| Angel | 1 | 13% |
| Series E | 1 | 13% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Youshi Technology | Youshi Technology is an automation company specializing in computer vision-based automatic driving of small unmanned vehicles. |  | Series B | Apr 26, 2026 |  |
| Gaosong Digital | Gaosong Digital is a data-centric intelligent service provider for digital transformation. |  | Angel | Aug 03, 2023 |  |
| Miaoshou Doctor | Miaoshou Doctor is a healthcare service platform for building an online communication service platform between patients and doctors.It helps healthcare professionals and patients to manage post-diagnosis outcomes and allows doctors to actively follow up with their patient's health through additional counseling and prescriptions.Tao He andDaoliang Han founded the company in 2015 and is based in Beijing, Beijing. | $232M | Series F | Aug 04, 2021 |  |
| Beijing Yuan Xin | Beijing Yuanxin is a technology company that offers an integrated healthcare platform for pharmaceutical distribution and health insurance. | $231.8M | Series F | Aug 03, 2021 |  |
| Yuanxin Huibao | Yuanxin Huibao is a health insurance technology service provider. It provides insurance for health care in major areas such as major diseases and chronic diseases. It provides users with more reliable medical and medical services and is more insurance. The company offers solutions such as “product actuarial pricing, risk control, user acquisitionand viscosity”. | $231.8M | Series F | Aug 03, 2021 |  |
| Miaoshou Doctor | Miaoshou Doctor is a healthcare service platform for building an online communication service platform between patients and doctors.It helps healthcare professionals and patients to manage post-diagnosis outcomes and allows doctors to actively follow up with their patient's health through additional counseling and prescriptions.Tao He andDaoliang Han founded the company in 2015 and is based in Beijing, Beijing. | $466.2M | Series E | Feb 09, 2021 |  |
| JD Health | JD Health is an e-commerce platform for pharmaceutical products such as vitamins & supplements, medical supplies, contact lenses, adult products, traditional medicine, and more. It is the digital healthcare subsidiary of JD.com. | $830M | Series B | Aug 17, 2020 |  |
| Job Cloud Education Technology Group | Job Cloud Education Technology Group offers an online education platform focusing on the vocational education field. |  | Series B | Apr 11, 2020 |  |

8 of 8 investments shown.

## Co-investors
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund, 4 deals together
- [CITIC Securities](https://shizune.co/investors/profile/citic-securities) — VC Fund, 3 deals together
- [E-Fund](https://shizune.co/investors/profile/e-fund) — VC Fund, 3 deals together
- Hel Ved Capital — VC Fund, 3 deals together
- Index Capital — VC Fund, 3 deals together
- [UOB Venture](https://shizune.co/investors/profile/uob-venture) — VC Fund, 3 deals together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Kun Ling Capital invest in?

Kun Ling Capital invests primarily in Health Care, Medical and EdTech startups, most often at Series B and Series F stage. Most of the 8 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Kun Ling Capital last invest?

The most recent investment recorded for Kun Ling Capital closed in Apr 2026. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co